NGS-Based RNA Sequencing Global Market Report 2022: With Illumina, Thermo Fischer Scientific, Oxford Nanopore, Agilent Technologies and BGI

Global NGS-Based RNA Sequencing Market

Dublin, Jan. 03, 2023 (GLOBE NEWSWIRE) — The ‘NGS-Based RNA-Sequencing Global Market Report 2022: Ukraine-Russia War Impact’ has been added to from ResearchAndMarkets.com offer.

The global NGS-based RNA sequencing market is expected to grow from $1.82 billion in 2021 to $2.21 billion in 2022 at a compound annual growth rate (CAGR) of 21.57%.

The NGS-based RNA sequencing market is expected to reach $5.04 billion in 2026 at a compound annual growth rate (CAGR) of 22.91%.

North America was the largest region in the NGS-based RNA sequencing market in 2021. Asia-Pacific is expected to be the fastest growing region during the forecast period. Regions covered in the NGS-based RNA Sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Growth in precision medicine is driving the NGS-based RNA sequencing market. Precision medicine helps doctors design individualized treatment plans and make treatment decisions based on a genetic understanding of the patient’s disease. There is a growth in precision drugs for the treatment of serious diseases such as cancer.

NGS-based RNA sequencing helps identify the root cause of disease and prescribe specific precision drugs for treatment. For example, in September 2021, the Swedish government invested $21.15 million (SEK 220 million) in the Swedish national infrastructure Genomic Medicine Sweden (GMS), to facilitate the continued integration of precision medicine into Swedish healthcare, ensuring that everyone there has access to more accurate testing and individualized care. These investments are taking place due to an increase in demand for precision drugs. As the demand for precision drugs increases, the demand for NGS-based RNA sequencing will also increase.

Strategic partnership is a key trend in the NGS-based RNA sequencing market. Companies partner with NGS-based RNA sequencing companies to expand into new markets and leverage each other’s resources. For example, in May 2022, the Biomedical Advanced Research and Development Authority (BARDA), a US Department of Health and Human Services, partnered with several industry and academic partners. The partnership aims to improve the ability to respond rapidly to public health emergencies and develop new diagnostic capability that covers all recognized and emerging RNA respiratory viruses in a single test.

The story continues

Reasons to buy

• Get a truly global perspective with the most comprehensive report available on this market covering over 12 geographies.

• Understand how the market is affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus diminishes.

• Russia Assessment – Impact of war on the supply of agricultural, energy and mineral products and their direct and indirect impact on the market analyzed in the report.

• Impact of high global inflation on market growth.

• Create regional and national strategies based on local data and analysis.

• Identify growth segments for investment.

• Outperform your competition using forecast data and the drivers and trends shaping the market.

• Understand customers based on the latest market research.

• Benchmark performance against leading competitors.

• Use relationships between key data sets for better strategy.

• Suitable to support your internal and external presentations with reliable high quality data and analysis

Scope
Covered markets:

1) By product and service: sample preparation products; Sequencing platforms and consumables; Sequencing services; Data analysis, storage and management
2) By Technology: Sequencing by Synthesis; sequencing of ion semiconductors; Real-time single molecule sequencing; Nanopore sequencing
3) By application: Expression profiling analysis; small RNA sequencing; De novo transcriptome assembly; Variant calling and transcriptome epigenetics
4) By the end user: research and academia; Hospitals & Clinics; Pharmaceutical and biotechnology companies; Other end users

Main topics covered:

1. Summary

2. Characteristics of the NGS-Based RNA Sequencing Market

3. NGS-Based RNA Sequencing Market Trends and Strategies

4. NGS-Based RNA Sequencing Market – Macroeconomic Scenario

5. NGS-Based RNA Sequencing Market Size and Growth

6. NGS-Based RNA Sequencing Market Segmentation

7. Regional and Country Analysis of NGS-Based RNA Sequencing Market

8. Asia-Pacific NGS-Based RNA Sequencing Market

9. China NGS-Based RNA Sequencing Market

10. NGS-Based RNA Sequencing Market in India

11. Japan NGS-Based RNA Sequencing Market

12. Australia NGS-Based RNA Sequencing Market

13. NGS-Based RNA Sequencing Market in Indonesia

14. South Korea NGS-Based RNA Sequencing Market

15. Western Europe NGS-Based RNA Sequencing Market

16. UK NGS-Based RNA Sequencing Market

17. Germany NGS-Based RNA Sequencing Market

18. France NGS-Based RNA Sequencing Market

19. Eastern Europe NGS-Based RNA Sequencing Market

20. NGS-Based RNA Sequencing Market in Russia

21. North America NGS-Based RNA Sequencing Market

22. US NGS-Based RNA Sequencing Market

23. South America NGS-Based RNA Sequencing Market

24. NGS-Based RNA Sequencing Market in Brazil

25. Middle East NGS-Based RNA Sequencing Market

26. Africa NGS-Based RNA Sequencing Market

27. NGS-Based RNA Sequencing Market Competitive Landscape and Company Profiles

28. Key mergers and acquisitions in the NGS-based RNA sequencing market

29. NGS-Based RNA Sequencing Market Future Outlook and Potential Analysis

30. Annex

Companies cited

For more information about this report visit https://www.researchandmarkets.com/r/ql4lf9

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, top companies, new products and the latest trends.

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900